Levophed (Noradrenaline Tartrate)

Norepinephrine binds directly to alpha‑1 adrenergic receptors on vascular smooth muscle, causing vasoconstriction and raising systemic vascular resistance. It also stimulates beta‑1 receptors in the heart, increasing contractility and heart rate, which together elevate mean arterial pressure quickly.

The dose of Levophed is individualized by the prescribing clinician based on the patient’s hemodynamic status, target mean arterial pressure, and response to therapy. Continuous infusion rates are titrated in real time using invasive blood pressure monitoring.

Safety data for Levophed in pregnancy and lactation are limited. It should only be used when the potential benefit justifies any potential risk to the fetus or infant, and the decision must be made by a qualified healthcare professional.

To order Levophed, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India supplies hospitals, pharmacies and procurement teams worldwide, and will request trade or institutional credentials before providing pricing, availability, shipping details (including cold‑chain where required) and import documentation.

Levophed primarily acts on alpha‑1 and beta‑1 receptors, providing strong vasoconstriction with modest inotropic support. Dopamine has dose‑dependent effects, stimulating dopaminergic, beta‑1, and alpha‑1 receptors. Clinicians often prefer norepinephrine for septic shock because it produces more predictable blood pressure elevation with fewer tachyarrhythmic events.

Levophed should be stored at 2‑8 °C in a refrigerator, protected from light. The solution must not be frozen or shaken. If the product is removed from refrigeration for short periods, it should be returned to the recommended temperature range promptly.

Levophed is supplied as a sterile injection for intravenous infusion. It is typically administered through a central venous catheter using a calibrated infusion pump, allowing precise titration of the dose to achieve the desired hemodynamic response.

Serious risks include severe hypertension, myocardial ischemia, arrhythmias, and tissue necrosis if the drug extravasates from the vein. Continuous monitoring of blood pressure, cardiac rhythm, and infusion site is essential to detect and manage these complications promptly.

Levophed is contraindicated in patients with known hypersensitivity to norepinephrine or any of its excipients. Caution is advised in individuals with uncontrolled hypertension, severe coronary artery disease, or peripheral vascular disease, where the drug’s potent vasoconstrictive effects may exacerbate underlying conditions.